Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/38742
Título : Anti HHV-1 and HHV-2 activity in vitro of abietic and dehydroabietic acid derivatives
Autor : Agudelo Gómez, Lee Solbay
Betancur Galvis, Liliana Amparo
González Cardenete, Miguel Ángel
metadata.dc.subject.*: Herpesvirus Humano 1
Herpesvirus 1, Human
Herpesvirus Humano 2
Herpesvirus 2, Human
Antivirales
Antiviral Agents
Ácido abiético
Abietic acid
Ácido deshidroabiético
Dehydroabietic acid
https://id.nlm.nih.gov/mesh/D018259
https://id.nlm.nih.gov/mesh/D018258
https://id.nlm.nih.gov/mesh/D000998
Fecha de publicación : 2012
Editorial : University of Salerno
Citación : Agudelo-Gómez, L. S., Betancur-Galvis, L. A., & González, M. A. (2012). Anti HHV-1 and HHV-2 activity in vitro of abietic and dehydroabietic acid derivatives. Pharmacologyonline, 1(1), 36-42.
Resumen : ABSTRACT: Herpes Simplex Virus types 1 and 2 (HHV-1 and HHV-2) are human neurotropic viruses that infect most commonly the oral and genital area, respectively. Resistant viral isolates can be observed especially in immunocompromised patients. This scenario has triggered the search for new antiherpetic agents, especially those with mechanisms of action different to nucleoside analogs. The antiviral activity in vitro for abietic and dehydroabietic acid and controls [acyclovir (ACV), and heparin (HEP)] was evaluated against HHV-1 and HHV-2 using end-point titration technique (EPTT) with a few modifications. The compounds methyl abietate [2], abietinal [4], 8,13(15)-abietadien-18-oic acid [5], methyl abieta-8,13(15)-dien-18-oate [6], 8,13(15)-abietadien-18- ol [7] and dehydroabietinol acetate [11] showed significant anti-herpetic activity of broad-spectrum.
ISSN : 1827-8620
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
GomezLee_2012_AntiHHV-1_Dehydroabietic_Acid.pdfArtículo de investigación706.18 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons